Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.Contraception. 1999 Jul; 60(1):51-3.C
Abstract
The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.
Links
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
10549453
Citation
Fong, Y F., and K Singh. "Effect of the Levonorgestrel-releasing Intrauterine System On Uterine Myomas in a Renal Transplant Patient." Contraception, vol. 60, no. 1, 1999, pp. 51-3.
Fong YF, Singh K. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient. Contraception. 1999;60(1):51-3.
Fong, Y. F., & Singh, K. (1999). Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient. Contraception, 60(1), 51-3.
Fong YF, Singh K. Effect of the Levonorgestrel-releasing Intrauterine System On Uterine Myomas in a Renal Transplant Patient. Contraception. 1999;60(1):51-3. PubMed PMID: 10549453.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
AU - Fong,Y F,
AU - Singh,K,
PY - 1999/11/5/pubmed
PY - 1999/11/5/medline
PY - 1999/11/5/entrez
KW - Biology
KW - Cancer
KW - Case Studies--women
KW - Contraception
KW - Contraceptive Agents
KW - Contraceptive Agents, Female
KW - Contraceptive Agents, Progestin
KW - Contraceptive Methods
KW - Diseases
KW - Endometrial Cancer
KW - Family Planning
KW - Genitalia
KW - Genitalia, Female
KW - Iud
KW - Iud, Hormone Releasing
KW - Levonorgestrel
KW - Menorrhagia
KW - Menstruation Disorders
KW - Neoplasms
KW - Physiology
KW - Renal Effects
KW - Research Methodology
KW - Studies
KW - Urogenital Effects
KW - Urogenital System
KW - Uterine Effects
KW - Uterus
KW - Women
SP - 51
EP - 3
JF - Contraception
JO - Contraception
VL - 60
IS - 1
N2 - The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.
SN - 0010-7824
UR - https://www.unboundmedicine.com/medline/citation/10549453/Effect_of_the_levonorgestrel_releasing_intrauterine_system_on_uterine_myomas_in_a_renal_transplant_patient_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0010-7824(99)00061-X
DB - PRIME
DP - Unbound Medicine
ER -
